GlassScriptPhysician profile
Stephen James Annest
NPI 1093792590
$28,247.95
in general payments reported to CMS, 2019-2025
27 companies · $2,206 in 2025
The $2,206 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $127 · 2021: $4,348 · 2022: $19K · 2023: $257 · 2024: $836 · 2025: $2,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,715 · Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,715.27 |
| Food and Beverage | $583.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22,418.15 | 2019-2022 | |
| Angiodynamics, INC. | $2,766.33 | 2019-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Medtronic Vascular, INC. | $1,493.21 | 2019-2020 | |
| Veryan Medical Incorporated | $317.20 | 2021 | |
| Lemaitre Vascular, INC. | $258.58 | 2023-2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Xenosure Biologic Patch |
| Abbott Laboratories | $196.12 | 2021 | |
| Medtronic, INC. | $139.02 | 2021-2024 | Endurant Iis, Closurefast |
| Inari Medical, INC. | $91.42 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $74.90 | 2022-2025 | Grafix Pl, Regranex, Collagenase Santyl |
| Baxter Healthcare | $68.78 | 2021-2022 | |
| Boston Scientific Corporation | $51.90 | 2022-2025 | Varithena Administration Pack |
| Philips North America LLC | $39.95 | 2023 | |
| Cvrx, INC. | $38.87 | 2023 | Barostim Neo System |
| Medline Industries LP | $32.96 | 2019-2022 | |
| Avanos Medical | $32.36 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $28.93 | 2019-2020 | |
| Pfizer INC. | $22.09 | 2021 | |
| Cardinal Health 200 LLC | $20.73 | 2020 | |
| Shockwave Medical, INC | $19.50 | 2022 | |
| Silk Road Medical, INC. | $19.23 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Dilon Technologies, INC. | $18.88 | 2023 | Hemoblast Bellows |
| Integra Lifesciences Corporation | $18.86 | 2021 | |
| Centerline Biomedical INC. | $18.86 | 2022 | |
| Ossur Americas, INC. | $17.61 | 2024 | |
| Acera Surgical, INC. | $15.32 | 2023 | Restrata Wound Matrix |
| Acell, INC. | $14.14 | 2019 | |
| Baudax Bio INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Annest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.